v


Xiaogan Central Hospital Completes Two Single-Port Robotic Surgeries in One Day

 

Xiaogan Central Hospital recently introduced the globally advanced SHURUI® single-port surgical robot, marking a milestone in minimally invasive surgery and the commercial adoption of high-end domestic medical technology in a prefecture-level hospital.

 

Soon after deployment and training, the surgical team independently performed the  single-port robotic surgeries. Led by Director Zhuo Wei from Urology, the team completed a textbook-level left kidney tumor resection and a right kidney cyst removal through a single tiny incision using the SHURUI® robot’s three flexible snake arms and 2.5cm sheath.

 

Both surgeries featured minimal bleeding, rapid patient recovery, and significantly reduced pain and infection risks. The procedures demonstrate SHURUI® robot’s superior precision and flexibility in complex anatomical regions, advancing Xiaogan’s medical technology to new heights.

 

Director Wei highlighted the robot’s expanded surgical field, enhanced dexterity, and improved patient outcomes, reinforcing the hospital’s confidence in promoting this innovative technology.

 

With strong leadership support and cross-department collaboration, Xiaogan Central Hospital plans to expand SHURUI® robot applications across multiple specialties, bringing cutting-edge, minimally invasive treatment to more patients.

 

 

Important Notes

The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.


Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.